239 related articles for article (PubMed ID: 24220299)
1. Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity.
Malik A; Sharma D; St Charles J; Dybas LA; Mansfield LS
Mucosal Immunol; 2014 Jul; 7(4):802-17. PubMed ID: 24220299
[TBL] [Abstract][Full Text] [Related]
2. Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.
Brooks PT; Brakel KA; Bell JA; Bejcek CE; Gilpin T; Brudvig JM; Mansfield LS
Microbiome; 2017 Aug; 5(1):92. PubMed ID: 28789710
[TBL] [Abstract][Full Text] [Related]
3. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
[TBL] [Abstract][Full Text] [Related]
4.
Malik A; Brudvig JM; Gadsden BJ; Ethridge AD; Mansfield LS
Gut Microbes; 2022; 14(1):2064706. PubMed ID: 35442154
[No Abstract] [Full Text] [Related]
5. Campylobacter jejuni induces colitis through activation of mammalian target of rapamycin signaling.
Sun X; Threadgill D; Jobin C
Gastroenterology; 2012 Jan; 142(1):86-95.e5. PubMed ID: 21963787
[TBL] [Abstract][Full Text] [Related]
6. An antibiotic depleted microbiome drives severe Campylobacter jejuni-mediated Type 1/17 colitis, Type 2 autoimmunity and neurologic sequelae in a mouse model.
Brooks PT; Bell JA; Bejcek CE; Malik A; Mansfield LS
J Neuroimmunol; 2019 Dec; 337():577048. PubMed ID: 31678855
[TBL] [Abstract][Full Text] [Related]
7. C57BL/6 and congenic interleukin-10-deficient mice can serve as models of Campylobacter jejuni colonization and enteritis.
Mansfield LS; Bell JA; Wilson DL; Murphy AJ; Elsheikha HM; Rathinam VA; Fierro BR; Linz JE; Young VB
Infect Immun; 2007 Mar; 75(3):1099-115. PubMed ID: 17130251
[TBL] [Abstract][Full Text] [Related]
8. Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice.
Haag LM; Fischer A; Otto B; Plickert R; Kühl AA; Göbel UB; Bereswill S; Heimesaat MM
PLoS One; 2012; 7(5):e35988. PubMed ID: 22563475
[TBL] [Abstract][Full Text] [Related]
9. Genetic background of IL-10(-/-) mice alters host-pathogen interactions with Campylobacter jejuni and influences disease phenotype.
Mansfield LS; Patterson JS; Fierro BR; Murphy AJ; Rathinam VA; Kopper JJ; Barbu NI; Onifade TJ; Bell JA
Microb Pathog; 2008 Oct; 45(4):241-57. PubMed ID: 18586081
[TBL] [Abstract][Full Text] [Related]
10. Absence of Nucleotide-Oligomerization-Domain-2 Is Associated with Less Distinct Disease in
Heimesaat MM; Grundmann U; Alutis ME; Fischer A; Bereswill S
Front Cell Infect Microbiol; 2017; 7():322. PubMed ID: 28752081
[TBL] [Abstract][Full Text] [Related]
11. IL-23 Contributes to
Jing X; Korchagina AA; Shein SA; Muraoka WT; Koroleva E; Tumanov AV
Front Immunol; 2020; 11():579615. PubMed ID: 33488580
[TBL] [Abstract][Full Text] [Related]
12. Th1/Th17-mediated Immunity and Protection from Peripheral Neuropathy in Wildtype and IL10
Brudvig JM; Cluett MM; Gensterblum-Miller EU; Chen J; Bell JA; Mansfield LS
Comp Med; 2022 Apr; 72(2):63-77. PubMed ID: 35272743
[No Abstract] [Full Text] [Related]
13. Nucleotide-binding oligomerization domain-containing protein 2 controls host response to Campylobacter jejuni in Il10-/- mice.
Sun X; Jobin C
J Infect Dis; 2014 Oct; 210(7):1145-54. PubMed ID: 24620022
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity and cytokines in Guillain-Barré syndrome revisited: review of pathomechanisms with an eye on therapeutic options.
Ebrahim Soltani Z; Rahmani F; Rezaei N
Eur Cytokine Netw; 2019 Mar; 30(1):1-14. PubMed ID: 31074417
[TBL] [Abstract][Full Text] [Related]
15. Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via Toll-like-receptor-2 and -4 signaling.
Haag LM; Fischer A; Otto B; Plickert R; Kühl AA; Göbel UB; Bereswill S; Heimesaat MM
PLoS One; 2012; 7(7):e40761. PubMed ID: 22808254
[TBL] [Abstract][Full Text] [Related]
16. Outcome of infection of C57BL/6 IL-10(-/-) mice with Campylobacter jejuni strains is correlated with genome content of open reading frames up- and down-regulated in vivo.
Bell JA; Jerome JP; Plovanich-Jones AE; Smith EJ; Gettings JR; Kim HY; Landgraf JR; Lefébure T; Kopper JJ; Rathinam VA; St Charles JL; Buffa BA; Brooks AP; Poe SA; Eaton KA; Stanhope MJ; Mansfield LS
Microb Pathog; 2013 Jan; 54():1-19. PubMed ID: 22960579
[TBL] [Abstract][Full Text] [Related]
17. The immunobiology of Campylobacter jejuni: Innate immunity and autoimmune diseases.
Phongsisay V
Immunobiology; 2016 Apr; 221(4):535-43. PubMed ID: 26709064
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase-γ signaling promotes Campylobacter jejuni-induced colitis through neutrophil recruitment in mice.
Sun X; Liu B; Sartor RB; Jobin C
J Immunol; 2013 Jan; 190(1):357-65. PubMed ID: 23180818
[TBL] [Abstract][Full Text] [Related]
19. Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection.
Edwards LA; Nistala K; Mills DC; Stephenson HN; Zilbauer M; Wren BW; Dorrell N; Lindley KJ; Wedderburn LR; Bajaj-Elliott M
PLoS One; 2010 Nov; 5(11):e15398. PubMed ID: 21085698
[TBL] [Abstract][Full Text] [Related]
20. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
Koga M; Yuki N; Takahashi M; Saito K; Hirata K
J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
